PCVAX
Price
$13.30
Change
+$0.30 (+2.31%)
Updated
Jun 2 closing price
Net Assets
248.41M
UBVVX
Price
$84.04
Change
+$0.45 (+0.54%)
Updated
Jun 2 closing price
Net Assets
8.91B
Interact to see
Advertisement

PCVAX vs UBVVX

Header iconPCVAX vs UBVVX Comparison
Open Charts PCVAX vs UBVVXBanner chart's image
PCVAX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
PCVAX vs. UBVVX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVAX is a Hold and UBVVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 8.91B vs. PCVAX (248M). UBVVX pays higher dividends than PCVAX: UBVVX (1.68) vs PCVAX (0.72). PCVAX was incepted earlier than UBVVX: PCVAX (29 years) vs UBVVX (9 years). PCVAX (1.24) is less costly to investors than UBVVX (0.94). PCVAX is a more actively managed with annual turnover of: 48.00 vs. UBVVX (35.00). UBVVX has a lower initial minimum investment than PCVAX: UBVVX (0) vs PCVAX (2500). PCVAX annual gain was more profitable for investors over the last year : 20.89 vs. UBVVX (7.97). UBVVX return over 5 years is better than : 4.89 vs. PCVAX (-13.62).
PCVAXUBVVXPCVAX / UBVVX
Total Expense Ratio1.170.90130%
Annual Report Gross Expense Ratio1.240.94132%
Fund Existence29 years9 years-
Gain YTD11.9726.934173%
Front Load6%N/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets248M8.91B3%
Annual Yield % from dividends0.721.6843%
Returns for 1 year20.897.97262%
Returns for 3 years18.7718.26103%
Returns for 5 years-13.624.89-278%
Returns for 10 years-31.83N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MITCX33.79N/A
N/A
MFS Massachusetts Investors Tr C
VCGAX37.34N/A
N/A
VALIC Company I Systematic Core Fund
WSEFX39.13N/A
N/A
Boston Trust Walden Equity
WOFDX63.91N/A
N/A
Allspring Opportunity Admin
MSJIX20.73N/A
N/A
Morgan Stanley Global Endurance I